GFRA1 and rectal cancer: In conclusion, the findings of this study support the method of aberrant DNA methylation of contiguous CpG sites using methylation arrays to detect potential molecular tumor biomarkers and indicate that further studies should be done on the role of GFRA1 and GSTM2 as potential molecular biomarkers of rectal cancer.